Ozurdex 2.0: The Game Has Changed

Show Description +

Michael Singer, MD, and Joshua Singer of the Medical Center Ophthalmology Associates in San Antonio, Texas demonstrates the new, sharper needle for the Ozurdex (dexamethasone intravitreal implant) 0.7 mg injection system. It compares it to the original needle, and shows how the new needle changes the experience for the patient, the staff and the doctor. To view the original video, click here.

Posted: 12/04/2012

Ozurdex 2.0: The Game Has Changed

Michael Singer, MD, and Joshua Singer of the Medical Center Ophthalmology Associates in San Antonio, Texas demonstrates the new, sharper needle for the Ozurdex (dexamethasone intravitreal implant) 0.7 mg injection system. It compares it to the original needle, and shows how the new needle changes the experience for the patient, the staff and the doctor. To view the original video, click here.

Posted: 12/04/2012

Please log in to leave a comment.

More in Retina

From Pixels to Pathology: The Synergy of DL-Driven OCT and Wide-field Color SLO with Functional Imaging

Akio Oishi, MD, PhD; Kunihiko Akiyama, MD, PhD; Jae Rock Do, MD, PhD; Haoyu Chen, MD, PhD

Handle Diabetic Surgery Like a Pro

Dimitra Skondra, MD, PhD, FASRS and Matthew A. Cunningham, MD

Trainees at VBS 2026

Alexis Cherry, MS and Jessica D. Randolph, MD

Tips and Tricks for Teaching Surgery

Michelle Liang, MD and Jordan D. Deaner, MD